UBS has maintained a Neutral rating on Nike stock following the company's fiscal first-quarter revenue falling short of estimates and its announcement of layoffs. Nike's shares dropped over 7% amid weak earnings guidance and expectations of further sales declines. Despite the stock's 80% fall from its peak, analysts see about 30% upside potential. The sell-off appears specific to Nike, as other athletic apparel stocks remain stable, highlighting investor concern over Nike's outlook and cost-cutting measures.
Following UBS's Neutral rating and Nike's revenue miss, Nike shares on Pluang have declined by 4.98% as of Oct 02, 2026 21:41 WIB, trading at USD 33.40. The stock shows a dividend yield of 4.63% and a market cap of $52.14 billion, with 61% of Pluang users buying and 39% selling, reflecting mixed investor sentiment.
Nike's stock has dropped 75% over five years, pushing its dividend yield close to 5%, signaling market concerns. The company hopes to replicate Michael Jordan's past success by launching the Caitlin 1, its largest women's signature shoe, which sold o...
Nike shares fell below their 52-week low amid a shrinking sales outlook and challenges in China, with revenue expected to decline in fiscal 2027. Despite this, Piper Sandler analyst Abbie Zvejnieks rates Nike as Overweight with a $75 price target, im...
Nike's shares fell over 8% following a weaker-than-expected first-quarter revenue report, largely impacted by struggles in its China market. The company announced a restructuring plan that includes layoffs next year and forecasted a high-single-digit...
Nike reported a 4% decline in Q1 sales, driven by a 22% drop in China revenue, impacting its overall performance and leading to a 9% premarket share decline. Moderna will replace Warner Bros Discovery in the Nasdaq-100, reflecting its strong market p...
Nike reported a 26% revenue decline in China and missed revenue expectations in its FY1Q27 results, though earnings slightly beat estimates. The company guided for a high single-digit revenue decline in FY2027, citing challenges like strong competiti...
